Cargando…

Novel pyrrolizines bearing 3,4,5-trimethoxyphenyl moiety: design, synthesis, molecular docking, and biological evaluation as potential multi-target cytotoxic agents

In the present study, two new series of pyrrolizines bearing 3,4,5-trimethoxyphenyl moiety were designed, synthesised, and evaluated for their cytotoxic activity. The benzamide derivatives 16a–e showed higher cytotoxicity than their corresponding Schiff bases 15a–e. Compounds 16a,b,d also inhibited...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shawky, Ahmed M., Ibrahim, Nashwa A., Abdalla, Ashraf N., Abourehab, Mohammed A. S., Gouda, Ahmed M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221158/ https://www.ncbi.nlm.nih.gov/pubmed/34154478 http://dx.doi.org/10.1080/14756366.2021.1937618

Ejemplares similares

Pharmacophore-based virtual screening, synthesis, biological evaluation, and molecular docking study of novel pyrrolizines bearing urea/thiourea moieties with potential cytotoxicity and CDK inhibitory activities
por: Shawky, Ahmed M., et al.
Publicado: (2020)

Pyrrolizine/Indolizine-NSAID Hybrids: Design, Synthesis, Biological Evaluation, and Molecular Docking Studies
por: Abourehab, Mohammed A. S., et al.
Publicado: (2021)

Pyrrolizine/indolizine-bearing (un)substituted isoindole moiety: design, synthesis, antiproliferative and MDR reversal activities, and in silico studies
por: AbdelSamad, Amr L., et al.
Publicado: (2023)

In Silico Approach Using Free Software to Optimize the Antiproliferative Activity and Predict the Potential Mechanism of Action of Pyrrolizine-Based Schiff Bases
por: Almalki, Faisal A., et al.
Publicado: (2021)

Design and Synthesis of New 4-(3,4,5-Trimethoxyphenyl)Thiazole–Pyrimidine Derivatives as Potential Antiproliferative Agents
por: El-Damasy, Ashraf K., et al.
Publicado: (2023)

Design, Synthesis, and Biological Evaluation of Some Novel Pyrrolizine Derivatives as COX Inhibitors with Anti-Inflammatory/Analgesic Activities and Low Ulcerogenic Liability
por: Gouda, Ahmed M., et al.
Publicado: (2016)

2-(3,4,5-Trimethoxyphenyl)-1H-benzimidazole
por: Khalaji, Aliakbar Dehno, et al.
Publicado: (2008)

Icotinib, Almonertinib, and Olmutinib: A 2D Similarity/Docking-Based Study to Predict the Potential Binding Modes and Interactions into EGFR
por: Almalki, Faisal A., et al.
Publicado: (2021)

Synthesis and cytotoxicity evaluation of novel 1,8-acridinedione derivatives bearing phthalimide moiety as potential antitumor agents
por: Khatab, Hassan A., et al.
Publicado: (2023)

Synthesis and Cytotoxic Activity of Novel Tetrahydrocurcumin Derivatives Bearing Pyrazole Moiety
por: Mahal, Ahmed, et al.
Publicado: (2017)

5-Methoxy-1-(3,4,5-trimethoxyphenyl)-1H-indole
por: Monroe, Thomas Blake, et al.
Publicado: (2010)

Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects
por: Alswah, Mohamed, et al.
Publicado: (2017)

2-(3,4,5-Trimethoxyphenyl)-1H-pyrrolo[2,3-b]pyridine
por: Selig, Roland, et al.
Publicado: (2009)

5-Chloro-2-(3,4,5-trimethoxyphenyl)-1,3-benzothiazole
por: Yousuf, Sammer, et al.
Publicado: (2012)

Design, synthesis, docking study and anticancer evaluation of new trimethoxyphenyl pyridine derivatives as tubulin inhibitors and apoptosis inducers
por: Hagras, Mohamed, et al.
Publicado: (2021)

Design, Synthesis, In Vitro Anticancer Evaluation and Molecular Modelling Studies of 3,4,5-Trimethoxyphenyl-Based Derivatives as Dual EGFR/HDAC Hybrid Inhibitors
por: Ibrahim, Tarek S., et al.
Publicado: (2021)

(Z)-3-(1H-Indol-3-yl)-2-(3,4,5-trimethoxyphenyl)acrylonitrile
por: Penthala, Narsimha Reddy, et al.
Publicado: (2012)

(Z)-3-(1-Benzofuran-2-yl)-2-(3,4,5-trimethoxyphenyl)acrylonitrile
por: Penthala, Narsimha Reddy, et al.
Publicado: (2012)

Coumarin derivatives bearing benzoheterocycle moiety: synthesis, cholinesterase inhibitory, and docking simulation study
por: Hirbod, Kimia, et al.
Publicado: (2017)

5-(3,4,5-Trimethoxyphenyl)-1,3,4-oxadiazole-2(3H)-thione
por: Saeed, Aamer, et al.
Publicado: (2010)

1-(4-Hydroxyphenyl)-3-(3,4,5-trimethoxyphenyl)thiourea
por: Choi, Hyeong, et al.
Publicado: (2010)

Synthesis, docking study and biological evaluation of some new thiourea derivatives bearing benzenesulfonamide moiety
por: Ghorab, Mostafa M., et al.
Publicado: (2017)

Conjugated Oligo-Aromatic Compounds Bearing a 3,4,5-Trimethoxy Moiety: Investigation of Their Antioxidant Activity Correlated with a DFT Study
por: Kareem, Huda. S., et al.
Publicado: (2016)

COX Inhibition Profile and Molecular Docking Studies of Some 2-(Trimethoxyphenyl)-Thiazoles
por: Oniga, Smaranda Dafina, et al.
Publicado: (2017)

Synthesis, Molecular Docking Study, and Cytotoxicity Evaluation of Some Novel 1,3,4-Thiadiazole as Well as 1,3-Thiazole Derivatives Bearing a Pyridine Moiety
por: Abouzied, Amr S., et al.
Publicado: (2022)

New peptide derived antimalaria and antimicrobial agents bearing sulphonamide moiety
por: Ugwuja, D. I., et al.
Publicado: (2019)

(E)-1-(2-Thienyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one
por: Suwunwong, Thitipone, et al.
Publicado: (2009)

Vanillin-Based Indolin-2-one Derivative Bearing a Pyridyl Moiety as a Promising Anti-Breast Cancer Agent via Anti-Estrogenic Activity
por: Bender, Onur, et al.
Publicado: (2023)

A Comprehensive Overview of Globally Approved JAK Inhibitors
por: Shawky, Ahmed M., et al.
Publicado: (2022)

Targeted Anticancer Immunotoxins and Cytotoxic Agents with Direct Killing Moieties
por: Kawakami, Koji, et al.
Publicado: (2006)

1-(2-Chloroacetyl)-3-methyl-2,6-bis(3,4,5-trimethoxyphenyl)piperidine-4-one
por: Lakshminarayana, B. N., et al.
Publicado: (2009)

(E)-1-(Pyridin-2-yl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one
por: Fun, Hoong-Kun, et al.
Publicado: (2011)

(E)-1-(4-Bromophenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one
por: Suwunwong, Thitipone, et al.
Publicado: (2008)

4,4,5,5-Tetramethyl-2-(3,4,5-trimethoxyphenyl)imidazolidine-1-oxyl 3-oxide
por: Wang, Hai-Bo, et al.
Publicado: (2009)

(E)-1-(2-Furyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one
por: Fun, Hoong-Kun, et al.
Publicado: (2010)

Design, synthesis and docking studies of novel thiazole derivatives incorporating pyridine moiety and assessment as antimicrobial agents
por: Khidre, Rizk E., et al.
Publicado: (2021)

Design, synthesis, cytotoxicity evaluation and docking studies of 1,2,4-triazine derivatives bearing different arylidene-hydrazinyl moieties as potential mTOR inhibitors
por: Ranjbar, Sara, et al.
Publicado: (2018)

Structure Activity Relationship and Molecular Docking of Some Quinazolines Bearing Sulfamerazine Moiety as New 3CLpro, cPLA2, sPLA2 Inhibitors
por: Hussein, Mohammed Abdalla, et al.
Publicado: (2023)

Synthesis, and docking studies of novel heterocycles incorporating the indazolylthiazole moiety as antimicrobial and anticancer agents
por: Dawoud, Nadia T. A., et al.
Publicado: (2022)

(E)-1-(4-Methoxyphenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one
por: Carvalho-Jr, P. S., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_pe9697onjqgoc1csa3vso67c4q